Synthetic Genomics, Archer Daniels Midland to Commercialize Omega-3 from Algae | GenomeWeb

NEW YORK (GenomeWeb) – Synthetic Genomics and Archer Daniels Midland today announced a deal to commercialize Omega-3 docosahexaenoic acid (DHA) from algae.

Typically found in fish and seafood products, DHA has been studied for the role it plays in brain, heart, and eye health. Extracting DHA directly from algae grown in fermentation tanks yields a "highly purified" form of DHA, which can be used as a dietary supplement for humans and in animal feed, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.